Lipocine Inc.
LPCN
$3.56
$0.257.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 180.32% | 27.69% | -187.33% | 253.95% | 65.68% |
| Total Depreciation and Amortization | 83.53% | 0.00% | 0.00% | 6.25% | 3.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.35% | -1,965.63% | 87.28% | 66.04% | -107.50% |
| Change in Net Operating Assets | 82.84% | -174.19% | 155.04% | -319.08% | -55.82% |
| Cash from Operations | 160.08% | -13.42% | -203.75% | 219.05% | 22.40% |
| Capital Expenditure | 87.52% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.06% | -76.80% | 216.20% | -249.49% | 120.10% |
| Cash from Investing | -25.56% | -78.48% | 216.20% | -249.99% | 119.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Financing | -- | -100.00% | 2,783.95% | -52.83% | -101.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.05% | -173.24% | 246.24% | -341.80% | 174.21% |